Sen-Jam Pharmaceutical
PrivateLast Round
Strategic
Dec 11, 2025
Est. Valuation
$150M
Total Funding Raised
$1.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sen-Jam Pharmaceutical is a biotechnology company that develops anti-inflammatory therapeutics by repurposing established molecules to address chronic inflammation and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sen-Jam Pharmaceutical Comparables
Compare Sen-Jam Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rejuvenate Biomed | 80% | |
| Hyloris Pharmaceuticals | 78% | |
| Biossil Inc. | 78% |
Sen-Jam Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 11, 2025 | ||||
| Convertible Debt | Jun 20, 2025 | ||||
| VC Round | Jan 22, 2025 | ||||
| Convertible Debt | Oct 3, 2024 | ||||
| Crowdfunding | Oct 14, 2022 | ||||
Strategic | Mar 22, 2022 |
Sen-Jam Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 5 Horizons Ventures | VC Round |
| Opus8 | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 1437% MoM, from 49 to 753.
- Jan 26, 2026
Monthly visitors increased 313% MoM, reaching 256.
Sen-Jam Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sen-Jam Pharmaceutical's valuation, stock price, and market status.
Is Sen-Jam Pharmaceutical a public or private company?
Sen-Jam Pharmaceutical is a private company.
What is the current stock price of Sen-Jam Pharmaceutical?
Sen-Jam Pharmaceutical is a private company, so its shares have no public market price. Caplight tracks Sen-Jam Pharmaceutical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sen-Jam Pharmaceutical worth (valuation)?
Sen-Jam Pharmaceutical's valuation is estimated at $150.0M based on funding round data.
Can I buy Sen-Jam Pharmaceutical stock?
Sen-Jam Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sen-Jam Pharmaceutical's last funding round?
Sen-Jam Pharmaceutical's most recent funding round was Strategic on December 11, 2025.
Who are the main investors in Sen-Jam Pharmaceutical?
Key investors in Sen-Jam Pharmaceutical include 5 Horizons Ventures.
Will Sen-Jam Pharmaceutical IPO soon?
No public IPO plans have been announced for Sen-Jam Pharmaceutical.
How can I track Sen-Jam Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades in Sen-Jam Pharmaceutical's shares on secondary markets.